Dr Ahmed Sokwala, MD, MMed, MRCP
Dr. Ahmed Sokwala, the Section Head of Nephrology, earned his medical degree at Marmara University, Istanbul, Turkey, and did his Internal Medicine Residency at Aga Khan University, Nairobi. He later pursued a Nephrology Fellowship at the University of Toronto, Canada. His current research interests include: epidemiology of renal disease in Kenya with a special interest in the epidemiology of end stage renal disease, glomerulonephritis, and chronic kidney disease. He is an active member of the American Society of Nephrology (ASN), Kenya Renal Association (KRA), and Canadian Society of Nephrology (CSN). Dr. Sokwala is also a member of the Royal College of Physicians
Varwani MH, Sokwala A. Saudi Treatment of steroid-resistant focal segmental glomerulosclerosis with rituximab: A case report and review of literature. Kidney Dis Transpl. 2017 (5):1175-1179. doi: 10.4103/1319-2442.215133.PMID: 28937082 Select item 27384362.
Kirui N, Sokwala A .A case of refractory thrombotic thrombocytopenic purpura treated with plasmapheresis and rituximab. S Afr Med J. 2016;106(7):689-91. doi: 10.7196/SAMJ. 2016.v106i7.9856. PMID: 27384362 Similar articles Select item 24606676.
Lick L, Shamy F, Nash M, Sokwala A, Malavade T, Prasad GR, Zaltzman JS. A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicity. Transplant Res. 2014;3(1):7. doi : 10.1186/2047-1440-3-7.PMID: 24606676 Free PMC Article Similar articles Select item 23849012
Malavade T, Sokwala A, Jassal SV. Clin Geriatr Dialysis therapies in older patients with end-stage renal disease. Med. 2013;29(3):625-39.
Part Time Faculty
Ahmed Twahir, MBChB, MMed, FIST, FERA
George Moturi MBChb , MMed